Introduction
Research and clinical trials are fundamental to delivering world‑class healthcare and improving outcomes for our community. They drive innovation, underpin evidence‑based practice, and ensure that care is grounded in the latest scientific knowledge. By embedding research into everyday clinical practice, as set out in this Strategy, NSLHD will continue to strengthen a learning health system that evolves in response to the needs of our patients. The NSLHD Research Directorate plays a central role in enabling this approach. It provides the strategic leadership, governance and partnerships required to move research efficiently from concept to delivery, and from discovery to impact—supporting clinicians, researchers and partners to translate evidence into improved care. This role has been significantly strengthened by the transformational $20 million philanthropic investment from Greg Poche and Kay Van Norton, which supported the establishment of the NORTH STAR Van Norton Poche Cancer Trials Centre. This investment marked a shift beyond a traditional governance function, expanding NSLHD’s research capability to include scaled trials delivery, deeper partnerships and a stronger focus on translation. Reflecting this, the Research Directorate is rebranded as NORTH Sydney Trials and Research (NORTH STAR) .
6
NSLHD Research Strategy to 2030
Made with FlippingBook - professional solution for displaying marketing and sales documents online